Drug major Ranbaxy Laboratories on Thursday said it plans to launch more generic products in the US market with possible marketing exclusivity, while keeping options open for overseas acquisitions......
Malvinder Mohan 'Malav' Singh, when he owned and ran Ranbaxy Laboratories (the Singh family sold the pharmaceutical company to Daiichi Sankyo of Japan in 2008; Malav exited the company a year......
Drug firm Ranbaxy Laboratories on Tuesday said its Romanian arm will market Daiichi Sankyo's drug Evista, used in treatment of osteoporosis, in the European country. Terapia (Terapia Ranbaxy), a......
In the two years since becoming CEO, Malvinder Mohan Singh has systematically purged risk out of Ranbaxy's model. Malvinder Mohan Singh, 35, does not mind wearing a T-shirt in office - tucked in.......
Indian pharmaceutical majors, such as Ranbaxy Lab and Dr Reddy's, are changing their tactics to concentrate on brand acquisitions and strategic investments rather than risky big ticket cross-border......